Premium
Zura Bio Ltd (ZURA)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutrali... Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California. Show more
TibuSURE is the first clinical trial designed to investigate anti-BAFF and IL-17 pathways in systemic sclerosis. TibuSURE launches with the initiation of its first clinical site. Zura Bio...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.555 | -22.2 | 2.5 | 2.61 | 1.86 | 327580 | 2.13392296 | CS |
| 4 | -0.625 | -24.3190661479 | 2.57 | 2.72 | 1.86 | 647460 | 2.39553371 | CS |
| 12 | -2.865 | -59.5634095634 | 4.81 | 4.96 | 1.86 | 481841 | 2.97642598 | CS |
| 26 | -1.735 | -47.1467391304 | 3.68 | 5.07 | 1.86 | 462937 | 3.5202189 | CS |
| 52 | -1.905 | -49.4805194805 | 3.85 | 6.35 | 1.86 | 361401 | 3.51366614 | CS |
| 156 | -6.055 | -75.6875 | 8 | 37.55 | 1.86 | 358972 | 6.05998155 | CS |
| 260 | -6.055 | -75.6875 | 8 | 37.55 | 1.86 | 358972 | 6.05998155 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
